These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
862 related articles for article (PubMed ID: 18335323)
1. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women. Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323 [TBL] [Abstract][Full Text] [Related]
2. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202 [TBL] [Abstract][Full Text] [Related]
3. Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours. Waksmański B; Dudkiewicz J; Kowalski T Med Sci Monit; 2001; 7(5):919-23. PubMed ID: 11535935 [TBL] [Abstract][Full Text] [Related]
4. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer]. Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562 [TBL] [Abstract][Full Text] [Related]
5. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339 [TBL] [Abstract][Full Text] [Related]
7. Relationships between leptin, insulin, IGF-1 and IGFBP-3 in children with energy malnutrition. Haspolat K; Ece A; Gürkan F; Atamer Y; Tutanç M; Yolbaş I Clin Biochem; 2007 Feb; 40(3-4):201-5. PubMed ID: 17208213 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. Flyvbjerg A; Mogensen O; Mogensen B; Nielsen OS J Clin Endocrinol Metab; 1997 Jul; 82(7):2308-13. PubMed ID: 9215312 [TBL] [Abstract][Full Text] [Related]
9. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992 [TBL] [Abstract][Full Text] [Related]
10. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [TBL] [Abstract][Full Text] [Related]
11. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360 [TBL] [Abstract][Full Text] [Related]
12. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer. Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts. Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148 [TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related]
16. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Toussirot E; Nguyen NU; Dumoulin G; Aubin F; Cédoz JP; Wendling D Rheumatology (Oxford); 2005 Jan; 44(1):120-5. PubMed ID: 15466894 [TBL] [Abstract][Full Text] [Related]
17. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075 [TBL] [Abstract][Full Text] [Related]
18. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer. Yilmaz O; Eroglu A; Dag E; Karaoglanoglu N; Yilmaz A Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680 [TBL] [Abstract][Full Text] [Related]
20. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]